Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production 2024-12-18 21:08
Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery 2024-12-18 13:09
U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) 2024-12-18 11:50
Neurizon Files IND Application to Support HEALEY ALS Platform Trial 2024-12-18 10:59
Origin Agritech Holds Successful 2025 R&D and Business Management Conference 2024-12-17 21:00
Great Bay Bio Completes First Close of Series B Financing 2024-12-17 16:42
Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin® 2024-12-17 09:00
SK Biopharmaceuticals Inks Research Collaboration Agreement with ProEn Therapeutics Further Accelerating Expansion of Oncology Research and Pipeline for Global Competitiveness in Radiopharmaceuticals 2024-12-17 08:20
Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index 2024-12-17 07:51
Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer 2024-12-17 02:05
Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg 2024-12-16 22:08
World's 1st Stem Cell Book on Animals, Reveals How to Extend the Lives of Pets 2024-12-16 22:00
Nona Biosciences Announces Discovery Collaboration with Candid Therapeutics for Next-Generation T-Cell Engagers 2024-12-16 20:03
HiRO Forges Strategic Partnership with CHA University Bundang Medical Center in South Korea 2024-12-16 10:30
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China 2024-12-16 07:55
Young International Scientists Say: China-Myanmar Partnership Advances Agricultural Innovation 2024-12-13 18:21
Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101 2024-12-13 12:57
Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024 2024-12-13 10:35
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS 2024-12-13 08:00
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS 2024-12-13 08:00
1 2 3 4 5 458